# Insulin Resistance in Non-alcoholic Fatty Liver Disease

> **NCT00252499** · NA · TERMINATED · sponsor: **US Department of Veterans Affairs** · enrollment: 13 (actual)

## Conditions studied

- Fatty Liver
- Insulin Resistance

## Interventions

- **DRUG:** rosiglitazone
- **DRUG:** fenofibrate
- **DRUG:** placebo for rosiglitazone
- **DRUG:** placebo for fenofibrate

## Key facts

- **NCT ID:** NCT00252499
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Protocol drug change required new clinicaltrails.gov entry
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252499, "Insulin Resistance in Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00252499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*